4.5 Article

Impaired proteasome function in Alzheimer's disease

Journal

JOURNAL OF NEUROCHEMISTRY
Volume 75, Issue 1, Pages 436-439

Publisher

WILEY
DOI: 10.1046/j.1471-4159.2000.0750436.x

Keywords

Alzheimer's disease; amyloid beta-peptide; neurodegeneration; oxidative stress; proteasome-ubiquitin

Funding

  1. NIA NIH HHS [1PO1-AG05119, 5P50-AG05144] Funding Source: Medline

Ask authors/readers for more resources

Inhibition of proteasome activity is sufficient to induce neuron degeneration and death; however, altered proteasome activity in a neurodegenerative disorder has not been demonstrated. In the present study, we analyzed proteasome activity in short-postmortem-interval autopsied brains from 16 Alzheimer's disease (AD) and nine age- and sex-matched controls. A significant decrease tn proteasome activity was observed in the hippocampus and parahippocampal gyrus (48%), superior and middle temporal gyri (38%), and inferior parietal lobule (28%) of AD patients compared with controls. In contrast. no significant decrease in proteasome activity was observed in either the occipital lobe or the cerebellum. The loss of proteasome activity was not associated with a decrease in proteasome expression, suggesting that the proteasome may become inhibited in AD by a posttranslational modification. Together. these data indicate a possible role for proteasome inhibition in the neurodegeneration associated with AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available